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LETTER TO THE EDITOR
Comparing symptomatic and screen-detected breast cancer
Sir - We read with interest the recent article by Rajakariar
and Walker (1995) on the pathological and biological
features of mammographically de invasive breast
cancer. Unfortunately one cannot extrapolate their findings
to screen-detected cancer as a whole as only impalpable
breast carcinomas were included in the study group. In Not-
tngham we have found that 51% of prevalent round
screening-detected invasive breast carcinomas are palpable.
The title is therefore mislading as it refers to mammog-
raphically detected cancer not m l yodhiaLi
and impalpable breast cancer. We have also found that pal-
pable and impalpable prevalent round see
invasive breast canrs have different grade and lymph node
stage characteristics. Palpable screen-detected cancers are
more hikely to be grade 3 and are more likely to have lymph
node metastases than impalpable screen-detected cancer
(patients with equivocal physical findings excluded).
Palpabk no. 1mpalpbl no.
(%) (%)
Hit l grade
1+2 68 (79) 51 (93)
3 18 (21) 4 (7)
Chi-square P = 0.05
Lymph node stage
negative 51 (70) 37 (86)
positive 22 (30) 6 (14)
Chi-square P = 0.03
The differences in the pathological and biological features of
screendetecd cancer (palpable and impalpable) and symp-
tomatic cancer are therefore hikely to be less marked than
suggested by Rajakariar and Walker.
Yours etc,
AJ Evans
M De Nunzio
IR Davidson
Nottingham National Breast Screening Tring Centre
City Hospital
Hucknall Road
Nottingham NG5 IPB, UK
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Reply to the letter from Evans et al
Sir - Dr Evans and his co-workers are concered that the
title of our recent paper relating to mammographically
deteted invasive breast cancinomas is mislading since it
does not state that all the cancers in the group studied were
impalpable and that, by selecting this group, it does not
reflect the distribution of carcinomas detected in the sreen-
ing programme.
One of the major problems with breast cancer is that there
is no clear understanding of the natural history of the
disease. The small, impalpable carcinomas detected by mam-
mography do provide a very useful group for analysis of the
earlier stages of the diseas. Our results suggest that breast
carcinomas probably have several different lines of develop-
ment and progression, with a proportion of impalpable car-
cinomas undergoing dedifferentiation with time.
The introduction of not only immunohistochemical app-
roaches, but also PCR-based techniques which can be app-
lied to formalin-fixed, paraffin-embedded tissue means that
these erly carciomas can be studied in depth for genetic
change Clarly what is needed are detailed comparative
analyses of the impalpable and palpable
cancers and the symptomatic cancers, if we are ever going to
understand this disease and improve therapeutic approaches.
TIhis is why we were particularly interested in resticting our
study to this group, rather than considering all cases detected
in the screening programme.
Yours etc,
RA Walker
R Rajakariar
Breast Cancer Research Unit
University of Leicester
Clinical Services
Gknfield General Hospital
Groby Road
Leicester LE3 9QP, UK